Ajax-Loading

Eli Lilly and Company - Financial Leverage Ratio

Eli Lilly and Company's Fiscal Year is From January To December.

The item "Financial-Leverage-Ratio" stands at 5.33 as of 09/30/2025.

As of the end of Eli Lilly and Company's third quarter, the item "Financial Leverage Ratio" stands at 5.33. This represents a decrease of -3.37 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.5401 percent compared to the value the year prior.
The 1 year change in percent is -0.5401.
The 3 year change in percent is 3.47.

The Serie's long term average value is 5.25. It's latest available value, on 09/30/2025, is 1.51 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is +11.79%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -9.60%.

Financial Leverage Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Financial Leverage Ratio486,508,953,600.00
LogoAbbVie Inc - Financial Leverage Ratio399,570,305,024.00
LogoRoche Holding AG - Financial Leverage Ratio317,433,206,677.55
LogoAstraZeneca PLC - Financial Leverage Ratio280,205,508,085.11
LogoNovartis AG - Financial Leverage Ratio255,096,620,580.91